生命科学资讯

Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO

Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reported

House backs Biosecure Act aimed at Chinese companies

Investors buy up stocks in biggest follow-on offering day in biotech history

Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backer

USAntibiotics scores sped-up approval for amoxicillin

Adare Pharma shutters Philadelphia site and lays off over 100 staffers

In a first, FDA approves a gene therapy from a nonprofit

J&J joins 'menin party' at ASH; GSK to work with Oxford BioTherapeutics

#SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%

PsiThera gets $47.5M for oral I&I drugs after spinning out from Roivant

Formation Bio signs deal for TYK2 drug from China's Lynk

UK lowers new medicine rebate scheme to 14.5% for 2026

D3 Bio raises $108M to take next-gen KRAS G12C drug into Phase 3

BlossomHill gets another $84M for macrocyclic approach to EGFR

FDA is taking another look at safety of approved RSV antibodies

Eli Lilly earmarks $6B for GLP-1 pill factory in Alabama

FDA's probe of Covid-19 vaccines expands into adults

#ASH25: New data from Gilead, J&J set up a bispecific, CAR-T rivalry

J&J-backed Cellular Origins raises $40M for cell therapy manufacturing